Shaw Christi
SEC insider (Form 3/4/5 filer). CIK 0001702473. Director at Beam Therapeutics Inc. (BEAM) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in CAMBRIDGE, MA.
Companies Shaw Christi has filed insider reports for
- Beam Therapeutics Inc. (BEAM): Director
- Kyverna Therapeutics, Inc. (KYTX): Director, Officer, Executive Chairperson
Shaw Christi
CIK: 0001702473
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 3, 2026BEAM
Beam Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
19.7K shares- - May 27, 2026KYTX
Kyverna Therapeutics, Inc.
Tax PaymentDirect4.2K shares at avg. $8.59$36K - Jan 12, 2026KYTX
Kyverna Therapeutics, Inc.
AwardDirect30K shares- - Jan 12, 2026KYTX
Kyverna Therapeutics, Inc.
AwardDirect24.3K shares- - Jun 4, 2025BEAM
Beam Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
33.7K shares- - May 29, 2025KYTX
Kyverna Therapeutics, Inc.
AwardDirect16.6K shares- - Feb 14, 2025KYTX
Kyverna Therapeutics, Inc.
AwardDirectStock Option (right to buy)
38.7K shares- - Sep 16, 2024KYTX
Kyverna Therapeutics, Inc.
AwardDirectStock Option (right to buy)
66.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  BEAM Beam Therapeutics Inc. | Award Stock Option (Right to Buy) | 19,676 | - | - | Direct |
| May 27, 2026 |  KYTX Kyverna Therapeutics, Inc. | Tax Payment | 4,194 | $8.59 | $36,026 | Direct |
| Jan 12, 2026 | KYTX Kyverna Therapeutics, Inc. | Award | 30,000 | - | $0 | Direct |
| Jan 12, 2026 | KYTX Kyverna Therapeutics, Inc. | Award | 24,301 | - | $0 | Direct |
| Jun 4, 2025 | BEAM Beam Therapeutics Inc. | Award Stock Option (Right to Buy) | 33,662 | - | - | Direct |
| May 29, 2025 | KYTX Kyverna Therapeutics, Inc. | Award | 16,634 | - | - | Direct |
| Feb 14, 2025 | KYTX Kyverna Therapeutics, Inc. | Award Stock Option (right to buy) | 38,679 | - | - | Direct |
| Sep 16, 2024 | KYTX Kyverna Therapeutics, Inc. | Award Stock Option (right to buy) | 66,592 | - | - | Direct |
1-8 of 8 transactions